It’s early days yet. But here’s what we know so far.
Academic rigor, journalistic flair
Articles on COVID-19 drug
Displaying all articles
Merck and Pfizer both have oral antiviral pills under review by the FDA. Such treatments could help turn the tide of the pandemic.
We’ve made a few mistakes in the past two years, when it comes to developing COVID drugs. Some were obvious and could have easily been avoided.
Paxlovid is one potential COVID drug for use at home. The idea is these can potentially be prescribed at the first sign of infection to prevent serious illness and death.
Top contributors
-
Emeritus Professor, University of South Australia
-
Professor of Medicine and Chair of Clinical Pharmacology, University of Newcastle
-
Associate Professor of the School of Pharmacy, University of Sydney
-
Pharmacist and PhD Candidate, University of Sydney
-
Assistant Professor of Infectious Diseases, University of Virginia
